NovaBay Pharmaceuticals, Inc. Income Statement
NBY / Health Care|15 years of annual SEC 10-K data (FY2010-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 9.3% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $18.2M | $11.9M | $4.4M | $370.0K | $3.3M | $6.9M | $11.0M | $9.8M |
| Cost of Revenue | $3.3M | $4.4M | $6.6M | $3.7M | $4.0M | $1.7M | $1.5M | $2.8M | $2.5M | $1.3M | $486.0K | $162.0K | $8.0K | - | - |
| Gross Profit | $6.5M | $6.1M | $7.8M | $6.5M | $6.0M | $4.9M | $11.0M | $15.4M | $9.4M | $3.1M | $568.0K | $3.3M | $6.0K | - | - |
| SG&A Expense | $7.4M | $5.4M | $7.5M | $7.2M | $5.9M | $5.3M | $5.8M | $8.6M | $7.2M | $18.1M | $7.9M | $6.3M | $6.0M | $5.4M | $5.7M |
| R&D Expense | $42.0K | $34.0K | $174.0K | $44.0K | $285.0K | $184.0K | $259.0K | $410.0K | $1.4M | $5.7M | $9.5M | $12.5M | $9.3M | $9.9M | $8.6M |
| Operating Income | -$5.8M | -$4.1M | -$14.4M | -$8.9M | -$6.4M | -$9.4M | -$7.9M | -$7.3M | -$11.0M | -$21.1M | -$16.9M | -$15.5M | -$8.3M | -$4.3M | -$4.5M |
| Income Tax | $0 | $0 | $0 | $0 | $5.0K | $6.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.6K | $2.0K | $2.0K | $50.0K |
| Net Income | -$7.2M | -$9.6M | -$10.6M | -$5.8M | -$11.0M | -$9.7M | -$6.5M | -$7.4M | -$13.2M | -$19.0M | -$15.2M | -$16.0M | -$7.0M | -$5.1M | -$4.3M |
| EPS (Basic) | -$2.53 | -$139.14 | -$10.10 | -$5.26 | -$0.31 | -$0.48 | -$0.39 | -$6.82 | -$7.65 | -$10.51 | -$0.24 | -$0.20 | -$0.18 | $22404.00 | -$0.18 |
| EPS (Diluted) | - | - | - | - | -$0.31 | -$0.48 | -$0.46 | -$6.82 | -$7.65 | -$10.51 | -$0.24 | -$0.20 | -$0.18 | $23115.00 | -$0.18 |
| Shares Outstanding | 4.9M | 11.2M | 2.0M | 43.7M | 35.1M | 21.6M | 17.1M | 15.3M | 3.5M | 2.1M | 44.6M | 36.9M | 28.6M | 23.4M | 23.3M |
| Gross Margin | - | - | - | - | - | - | - | 84.7% | 79.3% | 71.2% | 153.5% | 101.9% | 0.1% | - | - |
| Operating Margin | - | - | - | - | - | - | - | -40.1% | -92.3% | -482.5% | -4568.7% | -475.9% | -119.8% | -39.2% | -46.3% |
| Profit Margin | - | - | - | - | - | - | - | -40.6% | -110.5% | -433.1% | -4106.5% | -493.0% | -101.4% | -46.2% | -44.2% |